Massachusett’s Ocular Therapeutix, Inc. Sets Terms For $75 Million IPO

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ocular Therapeutix is looking to raise as much as $80 million in a forthcoming initial public offering, the company said today.

Bedford, Mass.-based Ocular Therapeutix said it plans to offer 5 million shares at $14 to $16 apiece, making the IPO worth $70 million to $80 million.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC